LataMed AI Corp. (OTC: LMED) announced that development of its mobile healthcare application has entered its final stage, with the company completing testing, optimization, and deployment preparation. The app is expected to be submitted for distribution and become available through the Apple App Store and Google Play in the coming weeks, subject to platform review. This move represents a transition from development to public availability, providing users with a primary mobile access point to the LataMed AI digital healthcare ecosystem.
The application is designed to offer a convenient interface for users to access supported healthcare services and digital tools. Future functionality may include patient-facing tools, healthcare-provider interaction, digital communications, access to medical information, and service coordination. The company emphasizes mobile accessibility as crucial for Latin America, where smartphones are a primary means of accessing digital services. By launching on both major app stores, LataMed AI aims to provide more direct user access and build infrastructure for future expansion.
This launch supports the company's longer-term strategy to connect patients, healthcare professionals, pharmacies, insurers, payment providers, and wellness organizations within an integrated digital healthcare environment. LataMed AI continues to develop AI-supported technologies such as CardioAI, PulmoAI, and NeuroAI, and intends for the mobile infrastructure to serve as an additional pathway for user and professional interaction with these tools, subject to regulatory and commercial implementation.
Dr. Kevin Rodan Levy, CEO of LataMed AI, stated, "Our mobile application is now moving from development toward deployment, and we believe we are approaching an important milestone. Our team is completing final testing and preparation, and we currently expect the app to become available in the coming weeks, subject to platform review processes." He added, "Mobile availability provides a direct connection between users and the digital healthcare ecosystem we are building. Our objective is to create a platform that is practical, accessible, and capable of expanding as we introduce additional services and AI-supported tools."
The company believes this release will be another step in moving its technology from development into user-facing infrastructure. Following the initial release, LataMed AI plans to evaluate additional functionality and integrations for future versions. The company will provide updates as milestones are completed.
For more information, visit https://latamed.ai or review filings with the U.S. Securities and Exchange Commission at www.sec.gov.
